Pronounced State-Level Disparities in Prescription of Cannabinoids to Medicaid Patients

INTRODUCTION: Dronabinol is approved in the USA for chemotherapy-induced nausea as well as vomiting and HIV-induced anorexia, while cannabidiol is primarily approved for childhood epileptic disorders Lennox-Gastaut and Dravet syndrome. The use pattern for these prescription cannabinoids in the USA i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Edward Y., McCall, Kenneth L., Piper, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Preclinical Science and Clinical Studies – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315157/
https://www.ncbi.nlm.nih.gov/pubmed/37404688
http://dx.doi.org/10.1159/000531058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315157/
https://www.ncbi.nlm.nih.gov/pubmed/37404688
http://dx.doi.org/10.1159/000531058

Ejemplares similares